{"id":"https://openalex.org/W7223463013","doi":"https://doi.org/10.2147/dddt.s639867","title":"Efficacy and Safety of Moderate-Dose Glucocorticoids with Tacrolimus in High-Risk Membranous Nephropathy: A Real-World Comparison of Three Immunosuppressive Regimens","display_name":"Efficacy and Safety of Moderate-Dose Glucocorticoids with Tacrolimus in High-Risk Membranous Nephropathy: A Real-World Comparison of Three Immunosuppressive Regimens","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223463013","doi":"https://doi.org/10.2147/dddt.s639867","pmid":"https://pubmed.ncbi.nlm.nih.gov/42953776","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13715842"},"language":"en","primary_location":{"id":"doi:10.2147/dddt.s639867","doi":"https://doi.org/10.2147/dddt.s639867","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s639867","pdf_url":"https://www.dovepress.com/article/download/121334","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/article/download/121334","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159385721","display_name":"Lu Sui","orcid":"https://orcid.org/0009-0002-1707-2302","observed_orcids":["https://orcid.org/0009-0002-1707-2302"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lu Sui","raw_affiliation_strings":["Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China"],"raw_orcid":"https://orcid.org/0009-0002-1707-2302","affiliations":[{"raw_affiliation_string":"Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134162000","display_name":"Yutong Ma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yutong Ma","raw_affiliation_strings":["Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159426193","display_name":"Xintian Yu","orcid":"https://orcid.org/0009-0007-1221-6617","observed_orcids":["https://orcid.org/0009-0007-1221-6617"]},"institutions":[{"id":"https://openalex.org/I2800959905","display_name":"Liaoning University of Traditional Chinese Medicine","ror":"https://ror.org/030e3n504","country_code":"CN","type":"education","lineage":["https://openalex.org/I2800959905"]},{"id":"https://openalex.org/I4405282348","display_name":"Xinglin College of Liaoning University of Traditional Chinese Medicine","ror":"https://ror.org/05q2frv51","country_code":"CN","type":"education","lineage":["https://openalex.org/I4405282348"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xintian Yu","raw_affiliation_strings":["Department of Integrated Traditional Chinese and Western Medicine, Liaoning University of Traditional Chinese Medicine Xinglin College, Shenyang, Liaoning, People's Republic of China"],"raw_orcid":"https://orcid.org/0009-0007-1221-6617","affiliations":[{"raw_affiliation_string":"Department of Integrated Traditional Chinese and Western Medicine, Liaoning University of Traditional Chinese Medicine Xinglin College, Shenyang, Liaoning, People's Republic of China","institution_ids":["https://openalex.org/I2800959905","https://openalex.org/I4405282348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108439443","display_name":"Yilin Meng","orcid":"https://orcid.org/0009-0003-9468-3956","observed_orcids":["https://orcid.org/0009-0003-9468-3956"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yilin Meng","raw_affiliation_strings":["Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China"],"raw_orcid":"https://orcid.org/0009-0003-9468-3956","affiliations":[{"raw_affiliation_string":"Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159452209","display_name":"Xuqi Cui","orcid":"https://orcid.org/0009-0003-1475-5156","observed_orcids":["https://orcid.org/0009-0003-1475-5156"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xuqi Cui","raw_affiliation_strings":["Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China"],"raw_orcid":"https://orcid.org/0009-0003-1475-5156","affiliations":[{"raw_affiliation_string":"Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148024612","display_name":"Hao Geng","orcid":"https://orcid.org/0009-0007-9831-3046","observed_orcids":["https://orcid.org/0009-0007-9831-3046"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hao Geng","raw_affiliation_strings":["Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China"],"raw_orcid":"https://orcid.org/0009-0007-9831-3046","affiliations":[{"raw_affiliation_string":"Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159386276","display_name":"Jian Zhang","orcid":"https://orcid.org/0009-0002-6663-608X","observed_orcids":["https://orcid.org/0009-0002-6663-608X"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jian Zhang","raw_affiliation_strings":["Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China"],"raw_orcid":"https://orcid.org/0009-0002-6663-608X","affiliations":[{"raw_affiliation_string":"Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5141253365","display_name":"Xiao Bai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91656880","display_name":"China Medical University","ror":"https://ror.org/032d4f246","country_code":"CN","type":"education","lineage":["https://openalex.org/I91656880"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiao Bai","raw_affiliation_strings":["Laboratory of Epigenetics, School of Life Sciences, China Medical University, Shenyang, Liaoning, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Epigenetics, School of Life Sciences, China Medical University, Shenyang, Liaoning, People's Republic of China","institution_ids":["https://openalex.org/I91656880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003381441","display_name":"Weihao Shang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91656880","display_name":"China Medical University","ror":"https://ror.org/032d4f246","country_code":"CN","type":"education","lineage":["https://openalex.org/I91656880"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Weihao Shang","raw_affiliation_strings":["Laboratory of Epigenetics, School of Life Sciences, China Medical University, Shenyang, Liaoning, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Epigenetics, School of Life Sciences, China Medical University, Shenyang, Liaoning, People's Republic of China","institution_ids":["https://openalex.org/I91656880"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022721952","display_name":"Li Sun","orcid":"https://orcid.org/0000-0002-9682-990X","observed_orcids":["https://orcid.org/0000-0002-9682-990X"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Li Sun","raw_affiliation_strings":["Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China"],"raw_orcid":"https://orcid.org/0000-0002-9682-990X","affiliations":[{"raw_affiliation_string":"Department of Nephrology, the First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China","institution_ids":["https://openalex.org/I4210140515"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5003381441","https://openalex.org/A5022721952"],"corresponding_institution_ids":["https://openalex.org/I4210140515","https://openalex.org/I91656880"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82152079,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"Volume 20","issue":null,"first_page":"1","last_page":"19"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/membranous-nephropathy","display_name":"membranous nephropathy","score":0.996999979019165},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9350000023841858},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immunosuppressive-regimens","display_name":"immunosuppressive regimens","score":0.8870000243186951},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.6779999732971191},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.9380000233650208},{"id":"https://openalex.org/keywords/serum-albumin","display_name":"serum albumin","score":0.777999997138977},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.9679999947547913},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.5730000138282776},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.8130000233650208},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.5690000057220459},{"id":"https://openalex.org/keywords/kdigo-guidelines","display_name":"KDIGO guidelines","score":0.7039999961853027},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.5630000233650208},{"id":"https://openalex.org/keywords/glomerulonephritis","display_name":"glomerulonephritis","score":0.6809999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8791999816894531},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.7440000176429749},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7002000212669373},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6186000108718872},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5386999845504761},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.5146999955177307},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5040000081062317},{"id":"https://openalex.org/C2780841215","wikidata":"https://www.wikidata.org/wiki/Q422549","display_name":"Glucocorticoid","level":2,"score":0.5004000067710876},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.48750001192092896},{"id":"https://openalex.org/C2775946357","wikidata":"https://www.wikidata.org/wiki/Q1713037","display_name":"Membranous nephropathy","level":4,"score":0.4596000015735626},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44110000133514404},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3912000060081482},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.3790999948978424},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.3610999882221222},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.33660000562667847},{"id":"https://openalex.org/C128057223","wikidata":"https://www.wikidata.org/wiki/Q420566","display_name":"Calcineurin","level":3,"score":0.326200008392334},{"id":"https://openalex.org/C2778330430","wikidata":"https://www.wikidata.org/wiki/Q249619","display_name":"Immunosuppressive drug","level":3,"score":0.31790000200271606},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.31380000710487366},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.3093999922275543},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2777999937534332},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27570000290870667},{"id":"https://openalex.org/C2776715498","wikidata":"https://www.wikidata.org/wiki/Q11426176","display_name":"Prednisolone","level":2,"score":0.26440000534057617},{"id":"https://openalex.org/C2777785397","wikidata":"https://www.wikidata.org/wiki/Q492194","display_name":"Group B","level":2,"score":0.260699987411499},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.2590000033378601},{"id":"https://openalex.org/C2780303639","wikidata":"https://www.wikidata.org/wiki/Q740909","display_name":"Kidney transplantation","level":3,"score":0.2556000053882599}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015433","descriptor_name":"Glomerulonephritis, Membranous","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.2147/dddt.s639867","doi":"https://doi.org/10.2147/dddt.s639867","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s639867","pdf_url":"https://www.dovepress.com/article/download/121334","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13715842","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13715842/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13715842/pdf/DDDT-20-639867.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Des Devel Ther","raw_type":"Text"},{"id":"pmid:42953776","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42953776","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug design, development and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:4a3939f709ee454ea183f1742c93e1b7","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/4a3939f709ee454ea183f1742c93e1b7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Drug Design, Development and Therapy, Vol Volume 20, Iss Issue 1, Pp 1-19 (2026)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/121334","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/efficacy-and-safety-of-moderate-dose-glucocorticoids-with-tacrolimus-i-peer-reviewed-fulltext-article-DDDT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/dddt.s639867","doi":"https://doi.org/10.2147/dddt.s639867","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s639867","pdf_url":"https://www.dovepress.com/article/download/121334","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1081981063","display_name":null,"funder_award_id":"82270778","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G2003324444","display_name":null,"funder_award_id":"XLYC2412031","funder_id":"https://openalex.org/F4320329895","funder_display_name":"Liaoning Revitalization Talents Program"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320329895","display_name":"Liaoning Revitalization Talents Program","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223463013.pdf","grobid_xml":"https://content.openalex.org/works/W7223463013.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W1504641084","https://openalex.org/W1524390679","https://openalex.org/W2002664599","https://openalex.org/W2033965404","https://openalex.org/W2057686869","https://openalex.org/W2069106710","https://openalex.org/W2139936128","https://openalex.org/W2150069482","https://openalex.org/W2470335436","https://openalex.org/W2532400747","https://openalex.org/W2565577788","https://openalex.org/W2570331126","https://openalex.org/W2581966123","https://openalex.org/W2603454576","https://openalex.org/W2638887585","https://openalex.org/W2736886413","https://openalex.org/W2793027888","https://openalex.org/W2936258218","https://openalex.org/W2968526958","https://openalex.org/W2981931437","https://openalex.org/W3003495029","https://openalex.org/W3039284170","https://openalex.org/W3040166305","https://openalex.org/W3188796555","https://openalex.org/W3200479416","https://openalex.org/W4200501674","https://openalex.org/W4220772982","https://openalex.org/W4224050822","https://openalex.org/W4282975006","https://openalex.org/W4290743263","https://openalex.org/W4308593410","https://openalex.org/W4321480401","https://openalex.org/W4353080252","https://openalex.org/W4382981961","https://openalex.org/W4384819294","https://openalex.org/W4389410577","https://openalex.org/W4392376056","https://openalex.org/W4396654322","https://openalex.org/W4399861119","https://openalex.org/W4400928588","https://openalex.org/W4403806423","https://openalex.org/W4404729601","https://openalex.org/W4407799466","https://openalex.org/W4410555964","https://openalex.org/W4410674921","https://openalex.org/W4411533978","https://openalex.org/W4413104806","https://openalex.org/W4413109019","https://openalex.org/W4414249282","https://openalex.org/W4415080599","https://openalex.org/W4415195744","https://openalex.org/W4417293053"],"related_works":["https://openalex.org/W4365148986","https://openalex.org/W4404780321","https://openalex.org/W1190767899","https://openalex.org/W7084145408","https://openalex.org/W7167507490","https://openalex.org/W2586234346","https://openalex.org/W6999332900","https://openalex.org/W7009440999","https://openalex.org/W2965856798","https://openalex.org/W3181289761"],"abstract_inverted_index":{"Objective:":[0],"This":[1,57,279],"study":[2,58,280],"was":[3,210,238],"designed":[4],"to":[5,60,240,295,302],"evaluate":[6],"the":[7,42,47,140,149,154,241],"efficacy":[8,311],"of":[9,72,147,171,254,268],"moderate-dose":[10],"glucocorticoid":[11,32],"(mGC)":[12],"combined":[13,88,95,103],"with":[14,20,26,75,89,96,104,166,250],"tacrolimus":[15],"(FK506)":[16],"in":[17,66,246,288],"high-risk":[18,67,76,248,289,307],"patients":[19,74,291],"membranous":[21,305],"nephropathy":[22],"(MN),":[23],"and":[24,37,80,101,111,114,121,134,157,163,174,196,220,243,257,263,270],"compare":[25],"two":[27],"widely":[28],"used":[29],"therapies:":[30],"full-dose":[31,86],"(GC)":[33],"plus":[34,40],"cyclophosphamide":[35],"(CTX),":[36],"rituximab":[38],"(RTX)":[39],"FK506,":[41],"latter":[43],"being":[44],"recommended":[45],"by":[46],"Kidney":[48],"Disease:":[49],"Improving":[50],"Global":[51],"Outcomes":[52,127],"(KDIGO)":[53],"Clinical":[54],"Practice":[55],"Guidelines.":[56],"aims":[59],"provide":[61,282],"evidence":[62,283],"for":[63,153,276,284],"individualized":[64,285],"treatment":[65,84,286],"MN.":[68],"Methods:":[69],"A":[70],"total":[71],"154":[73],"MN":[77,290],"were":[78,125,137,160,180],"enrolled":[79],"assigned":[81],"into":[82],"three":[83,141],"groups:":[85],"GC":[87,297],"CTX":[90],"group":[91,98,106,188],"(GC+CTX)":[92],"(n=53),":[93],"mGC":[94],"FK506":[97,105],"(mGC+FK506)":[99],"(n=51),":[100],"RTX":[102],"(RTX+FK506)":[107],"(n=50).":[108],"Baseline":[109],"clinical":[110],"laboratory":[112],"parameters":[113],"follow-up":[115],"data":[116],"at":[117,193,261],"1,":[118],"3,":[119],"6,":[120],"12":[122,145],"months":[123,146],"post-treatment":[124],"collected.":[126],"including":[128],"disease":[129],"remission":[130,151,169,191,259],"rates,":[131,133],"relapse":[132],"adverse":[135],"events":[136],"compared":[138],"among":[139],"groups.":[142],"Results:":[143],"At":[144],"follow-up,":[148],"overall":[150],"rates":[152,170,192,260],"GC+CTX,":[155],"mGC+FK506,":[156],"RTX+FK506":[158,244],"groups":[159],"94.4%,":[161],"94.1%,":[162],"82.0%,":[164],"respectively,":[165],"corresponding":[167],"complete":[168],"32.1%,":[172],"43.1%,":[173],"24.0%.":[175],"No":[176],"significant":[177],"intergroup":[178],"differences":[179],"observed":[181],"(":[182],"P":[183,217,231],">":[184,207],"0.05).":[185],"The":[186,235],"mGC+FK506":[187,236],"demonstrated":[189],"higher":[190],"both":[194],"3":[195,262],"6":[197,264],"months.":[198,265],"Multivariate":[199],"Cox":[200],"regression":[201],"indicated":[202],"that":[203],"baseline":[204],"serum":[205],"albumin":[206],"20":[208],"g/L":[209],"a":[211],"protective":[212],"factor":[213,227],"(HR":[214,228],"=":[215,218,229,232],"1.638,":[216],"0.004),":[219],"comorbid":[221],"diabetes":[222],"mellitus":[223],"an":[224,251],"independent":[225],"risk":[226],"0.617,":[230],"0.032).":[233],"Conclusion:":[234],"regimen":[237],"non-inferior":[239],"GC+CTX":[242],"regimens":[245],"treating":[247],"MN,":[249],"earlier":[252],"onset":[253],"therapeutic":[255],"effect":[256],"superior":[258],"Early":[266],"correction":[267],"hypoalbuminemia":[269],"strict":[271],"glycemic":[272],"control":[273],"are":[274,293],"critical":[275],"improving":[277],"prognosis.":[278],"may":[281],"selection":[287],"who":[292],"intolerant":[294],"high-dose":[296],"or":[298],"have":[299],"limited":[300],"access":[301],"RTX.":[303],"Keywords:":[304],"nephropathy,":[306],"group,":[308],"tacrolimus,":[309],"glucocorticoid,":[310]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-25T00:00:00"}